FDA Takes Important Steps to Increase Racial and Ethnic Diversity in Clinical Trials

SILVER SPRING, Md., April 13, 2022 -- Today, the U.S. Food and Drug Administration issued a new draft guidance to industry for developing plans to enroll more participants from underrepresented racial and ethnic populations in the U.S. into clinical...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials